Thomas Swan Holdings Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Thomas Swan Holdings Limited - overview
Established
1926
Location
Consett, -, UK
Primary Industry
Financial Services
About
Thomas Swan Holdings Limited is a leading manufacturer of performance and specialty chemicals, delivering solutions tailored for diverse industries such as pharmaceuticals, automotive, and electronics. Founded in 1926, Thomas Swan Holdings Limited specializes in the manufacture of specialty chemicals. The company operates globally with its headquarters located in Consett, United Kingdom. The current CEO is Harry Swan, who oversees the strategic direction of the company.
There is no mention of subsidiaries or significant changes in business strategy. Thomas Swan & Co. Ltd. specializes in the production of over 100 performance and specialty chemicals designed to meet the diverse needs of various industries.
The company's core offerings include performance chemicals, advanced materials, and custom manufacture services, which are tailored to solve specific challenges faced by its customers, ranging from pharmaceuticals to coatings and polymers. These products are engineered to enhance performance and efficiency, with applications that span multiple sectors including automotive, aerospace, and electronics. The company serves a global client base, exporting to over 80 countries, with notable markets in the United States, Europe, and Asia. Thomas Swan's commitment to quality and innovation positions it as a trusted partner for businesses seeking high-quality chemical solutions.
Thomas Swan & Co. Ltd. operates on a business-to-business (B2B) model, engaging in direct transactions with clients across various sectors. The company structures its revenue through long-term partnerships with manufacturers and distributors who require consistent supplies of specialty chemicals.
These transactions typically involve bulk orders and may include customized product offerings tailored to specific client needs. Although precise pricing details are proprietary, flagship products such as Casamed™ BKC are indicative of the company's premium positioning in the market. Revenue is generated through these direct sales, underpinning the company's financial stability while fostering ongoing relationships with its expansive international customer base.
Primary Industry
Financial Services
Sub Industries
Financial Services
Website
www.thomas-swan.co.uk
Total Amount Raised
Subscriber access only
Thomas Swan Holdings Limited - timeline of key events
Thomas Swan Holdings Limited - financials
| Fiscal Year Ended | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 |
|---|---|---|---|---|---|---|
| Revenue (USD) | 33,735,361 | 37,042,427 | 37,054,836 | - | - | - |
| % Revenue Growth (YoY) | - | 9.8% | 0.0% | - | - | - |
| EBITDA (USD) | 1,371,402 | 3,621,859 | 4,017,847 | - | - | - |
| Operating Income (USD) | 1,369,984 | 2,057,537 | 2,180,213 | - | - | - |
| Operating Margin | 4.1% | 5.6% | 5.9% | - | - | - |
| % EBITDA Margin | 4.1% | 9.8% | 10.8% | - | - | - |
| NET Income (USD) | 1,029,364 | 1,596,060 | 1,715,261 | - | - | - |
| % Net Margin | 3.1% | 4.3% | 4.6% | - | - | - |
Thomas Swan Holdings Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.